Evidence map›Paper›PMID 34584369›Full record

ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2021

Textbook Outcome as a measure of surgical quality assessment and prognosis in gastric neuroendocrine carcinoma: A large multicenter sample analysis.

Qiyue Chen, Zhongliang Ning, Zhiyu Liu, Yanbing Zhou, Qingliang He, Yantao Tian, Hankun Hao, Wei Lin, Lixin Jiang, Gang Zhao and 4 more

Abstract read
In one paragraph

Article in Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Qiyue ChenDepartment of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350001, China.
Zhongliang NingDepartment of Gastrointestinal Surgery, West District of the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China.
Zhiyu LiuDepartment of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350001, China.
Yanbing ZhouDepartment of Gastrointestinal Surgery, Affiliated Hospital of Qingdao University, Qingdao 266000, China.
Qingliang HeDepartment of Gastrointestinal Surgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Yantao TianDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Hankun HaoDepartment of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China.
Wei LinDepartment of Gastrointestinal Surgery and Gastrointestinal Surgery Research Institute, the Affiliated Hospital of Putian University, Putian 351106, China.
Lixin JiangDepartment of Gastrointestinal Surgery, Yantai Yuhuangding Hospital, Yantai 264099, China.
Gang ZhaoDepartment of Gastrointestinal Surgery, Renji Hospital, Shanghai Jiaotong University, Shanghai 200127, China.
Ping LiDepartment of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350001, China.
Chaohui ZhengDepartment of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350001, China.
Changming HuangDepartment of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350001, China.
Study Group for Gastric Neuroendocrine Tumors

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveQuality assurance is crucial for oncological surgical treatment assessment. For rare diseases, single-quality indicators are not enough. We aim to develop a comprehensive and reproducible measurement, called the "Textbook Outcome" (TO), to assess the quality of surgical treatment and prognosis of gastric neuroendocrine carcinoma (G-NEC) patients.

methodsData from patients with primary diagnosed G-NEC included in 24 high-volume Chinese hospitals from October 2005 to September 2018 were analyzed. TO included receiving a curative resection, ≥15 lymph nodes examined, no severe postoperative complications, hospital stay ≤21 d, and no hospital readmission ≤30 d after discharge. Hospital variation in TO was analyzed using a case mix-adjusted funnel plot. Prognostic factors of survival and risk factors for non-Textbook Outcome (non-TO) were analyzed using Cox and logistic models, respectively.

resultsTO was achieved in 56.6% of 860 G-NEC patients. TO patients had better overall survival (OS), disease-free survival (DFS), and recurrence-free survival (RFS) than non-TO patients (P<0.05). Moreover, TO patients accounted for 60.3% of patients without recurrence. Multivariate Cox analysis revealed non-TO as an independent risk factor for OS, DFS, and RFS of G-NEC patients (P<0.05). Increasing TO rates were associated with improved OS for G-NEC patients, but not hospital volume. Multivariate logistic regression revealed that non-lower tumors, open surgery, and >200 mL blood loss were independent risk factors for non-TO patients (P<0.05).

conclusionsTO is strongly associated with multicenter surgical quality and prognosis for G-NEC patients. Factors predicting non-TO are identified, which may help guide strategies to optimize G-NEC outcomes.

Indexed as

gastric neuroendocrine carcinomaprognosisrisk factorsurgical qualityTextbook Outcome

Identifiers

PMID34584369
PMCPMC8435827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.